Geropharm: Clinical Trials

23 trials sponsored by Geropharm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 2 unknown, 1 active not recruiting. 10 Not applicable, 7 Phase 3, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 10
Phase 37Completed 5, Active not recruiting 1, Unknown 1
Phase 16Completed 5, Unknown 1

Follow Geropharm: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
GP40221, ozempic - Pharmacokinetics, Safety Issues
Phase 1CompletedGeropharm1202023-06-302024-07-11
Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients
GP40321, Apidra® SoloStar®, RinGlar® - Type 1 Diabetes Mellitis
Phase 3CompletedGeropharm2242023-04-142025-07-22
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia
GP404141, Nplate - Drug Effect, Safety Issues
Phase 3Active not recruitingGeropharm1602023-04-042024-07-11
Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141
GP40141, Nplate - Pharmacodynamics, Pharmacokinetics
Phase 1UnknownGeropharm562022-06-032022-12-15
Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia)
GP30341 capsules 200 mg, Standard therapy - Pharmacokinetics, Safety Issues
Not applicableCompletedGeropharm2462022-03-172024-07-22
Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients
GP40081, NovoMix 30 - Diabetes Mellitus, Type 2, Diabetes Mellitus
Phase 3UnknownGeropharm2642020-01-202020-04-15
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)
GP30101, Prezista® - Bioequivalence
Not applicableCompletedGeropharm442019-06-062024-07-22
Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients
GP40071, NovoRapid® Penfill® - Diabetes, Diabetes Mellitus, Type 1
Phase 3CompletedGeropharm2642019-06-032020-07-23
A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects
GP-40081, NovoMix® 30 Penfill® - Clamp Study
Not applicableCompletedGeropharm342019-04-152019-12-03
A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects
Insulin Aspart, NovoRapid® Penfill® - Clamp Study
Not applicableCompletedGeropharm262018-10-182019-12-03
Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients
Lantus Solostar, 100 Units/mL Subcutaneous Solution, Insulin RinGlar, 100 Units/mL Subcutaneous Solution - Diabetes Mellitus, Type 1, Diabetes Mellitus
Phase 3CompletedGeropharm1802018-07-042019-07-17
Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects
Bosentan 125 mg, Tracleer 125Mg Tablet - Bioequivalence
Phase 1CompletedGeropharm642018-05-242019-09-24
Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients
Humalog Mix25, Insulin Lispro Biphasic 25 - Diabetes Mellitus, Type 2, Diabetes Mellitus
Phase 3CompletedGeropharm2102018-03-142019-07-17
Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method
Humulin® Regular, Rinsulin® R - Bioequivalence, Therapeutic Equivalency
Not applicableCompletedGeropharm202018-02-192023-09-22
Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
Rinsulin NPH, Humulin NPH - Pharmacokinetics, Bioequivalence
Not applicableCompletedGeropharm522017-10-232020-08-06
A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients
RinGlar®, Lantus® - Clamp Study
Not applicableCompletedGeropharm422017-10-162019-09-24
Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
Rinsulin® mix 30/70, Humulin® M3 - Bioequivalence
Not applicableCompletedGeropharm322017-07-182020-08-05
Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions
Metformine, Glucophage® Long, Metformin - Bioequivalence
Phase 1CompletedGeropharm282017-06-152018-07-03
Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients
Insulin Humulin® NPH, Insulin Rinsulin® NPH - Diabetes Mellitus, Type 2
Phase 3CompletedGeropharm2012017-04-202019-07-09
A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects
Insulin Lispro Mix 25, Humalog® Mix 25 - Clamp Study
Not applicableCompletedGeropharm482017-04-122018-07-31

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Diabetes Mellitus (5)  ·  Insulin Resistance (4)  ·  Diabetes Mellitus, Type 2 (3)  ·  Fasting (3)  ·  Diabetes Mellitus, Type 1 (2)  ·  Lecithin Cholesterol Acyltransferase Deficiency (2)  ·  COVID-19 (1)

Interventions

Insulin Glargine (3)  ·  Insulin Aspart (2)  ·  Metformin (2)  ·  insulin aspart, insulin aspart protamine drug combination 30:70 (2)  ·  romiplostim (2)  ·  Bosentan (1)  ·  Darunavir (1)  ·  Drug Evaluation (1)  ·  Insulin Lispro (1)  ·  Isophane Insulin, Human (1)  ·  Memantine (1)  ·  Standard of Care (1)  ·  Tablets (1)  ·  insulin glulisine (1)  ·  insulin lispro, isophane insulin lispro drug combination (25:75) (1)

Countries

Russia (23)

Top investigators

Aleksandr Yu Mayorov, MD (1)  ·  Bulat Bakirov, MD (1)  ·  Dmitry Kirtbaya (1)  ·  Elena Borisenkova (1)  ·  Elizaveta Antonova (1)  ·  Galina Salogub (1)  ·  Igor Davydkin (1)  ·  Igor Makarenko, MD, PhD (1)  ·  Igor Mr Makarenko, PhD (1)  ·  Lubov Shpagina, MD (1)  ·  Olga A Miroshnichenko, PhD (1)  ·  Olga Vinogradova (1)  ·  Sergei Mr Noskov, AP of medicine (1)  ·  Sergei Noskov, MD, Pr. (1)  ·  Sergey M Noscor, MD, Doctor of science (1)

Results publications

PMID 32027167, PMID 33355484, PMID 33928797, PMID 37740581, PMID 40708707, PMID 41366610